title: Hypertension: SGLT2 inhibitors: not just another glucose-lowering agent.
authors.affiliation: Department of Medicine, ASH Comprehensive Hypertension Center, Section of Endocrinology, Diabetes and Metabolism, The University of Chicago Medicine, Chicago, 5841 South Maryland Avenue, MC 1027, Chicago, Illinois 60637, USA.
authors.forename: Hillel
authors.initials: H
authors.lastname: Sternlicht
authors.affiliation: Department of Medicine, ASH Comprehensive Hypertension Center, Section of Endocrinology, Diabetes and Metabolism, The University of Chicago Medicine, Chicago, 5841 South Maryland Avenue, MC 1027, Chicago, Illinois 60637, USA.
authors.forename: George L
authors.initials: GL
authors.lastname: Bakris
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005947:Glucose; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D005947:Glucose